Ex post facto drug management system is ineffective under new drug plan

Published: 2002-11-22 06:58:00

Updated: 2002-11-22 06:58:00

Pharmaceutical business sources say that if a new drug price re-evaluation system is firmly established next year, the existing ex post facto drug management system, which has been regularly implemented four times a year, is indeed ineffective in that the new system may cover the price-adjustment...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK